Sidus’ Acquisition of Pierre Fabre Dermo Cosmétique Argentina and Rovafarm Argentina S.A.


Ortiz & Asociados and KPMG advised on the deal

Sidus executed the acquisition of Pierre Fabre Dermo Cosmétique Argentina and Rovafarm Argentina S.A.

Rovafarm Argentina S.A. is part of Pierre Fabre Medicament’s Chemical branch, since 1989.

Rovafarm has a strong expertise in Animal raw material Extraction and is widely known as one of the biggest players in the Chondroitin sulfate business. It now offers Chenodeoxycholic acid.

Pierre Fabre Dermo Cosmétique Argentina engages in cosmetic business.

Ortiz & Asociados advised Sidus with a team including Jorge D. Ortiz (Picture), Vanesa Fernanda Mahia (M&A),

Juan Pablo Rovira (Employment) and Laura Mattivi (M&A).

KPMG advised Pierre Fabre with a team including Juan Martín Jovanovich, María Ximena Pérez Dirrocco, Mariana Degastaldi (M&A) and Analía Saitta, Andrés Tellado Canas and María Alejandra Mancino (Employment).

Involved fees earner: Mariana Degastaldi – KPMG; Juan Martín Jovanovich – KPMG; María Alejandra Mancino – KPMG; María Ximena Pérez Dirrocco – KPMG; Analía Saitta – KPMG; Andrés Tellado Canas – KPMG; Vanesa Mahia – Ortiz & Asociados; María Laura Mattivi Aboy – Ortiz & Asociados; Jorge Ortiz – Ortiz & Asociados; Juan Pablo Rovira Escalante – Ortiz & Asociados;

Law Firms: KPMG; Ortiz & Asociados;

Clients: Pierre Fabre S.A.; Sidus Investment Management LLC;

Author: Ambrogio Visconti.